Somamers Somalogic Using DeCode Deal to Drive Development of Clinical Proteomics Pipeline Premium The firm is using collaborations to access the large, diverse cohorts it needs to support its goal of commercializing its SomaScan system as a clinical platform. Somalogic, DeCode Collaborating on Proteomic Project The companies will use Somalogic's SomaScan proteomic platform to measure levels of as many as 5,000 proteins in up to 40,000 of DeCode's patient samples. European Consortium Aims to Deliver New Tests, Therapies for Cardiovascular Diseases Premium Backed by €19 million in EU funding, the initiative, called [email protected], will create a research platform that could change the way cardiovascular diseases are diagnosed and treated. SomaLogic Inks Deal With BMS for Use of SOMAscan Platform Under the agreement, BMS has access to the 1,310 reagents in the public version of SomaLogic's SOMAscan assay along with a number of custom-developed reagents. Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma Premium Proteomics diagnostics firm Somalogic reported data this week supporting the utility of its blood-based 13-protein panel for the detection of malignant mesothelioma. Apr 20, 2012 Somalogic Publishes First Data on Use of Somascan in Tissue Samples, Considers Offering Reagents for IHC Premium Apr 13, 2012 Somalogic Teams with HUNT for 2,000-Patient Validation Study of Cardiovascular Biomarkers Premium Oct 21, 2011 With Novartis Deal, Release of New Discovery Panel, Somalogic Targets Proteomics Services Market Premium Jul 28, 2011 SomaLogic to Provide Reagents for New England Biolabs' PCR Products Premium Jul 27, 2011 SomaLogic, New England Biolabs Partner on PCR Products May 7, 2011 Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research Premium Apr 22, 2011 NCI's Early Detection Research Network Running Trials to Compare Biomarker-Based Cancer Diagnostics Premium Apr 8, 2011 NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma Premium Dec 10, 2010 SomaLogic Launching Validation and Prospective Trials for Protein Biomarker Lung Cancer Diagnostic Premium Oct 15, 2010 Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma Premium Sep 10, 2010 Somalogic Partners with NEC in Effort to More Broadly Leverage Aptamer-Based Technology Premium Breaking News Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs Yourgene Health Enters Three-Year £5M Term Loan Facility The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.